We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$27.2B
1-Year Est. Return
43.16%
This Fund
S&P 500
This Quarter
Est. Return
+9.53%
1 Year Est. Return
+43.16%
3 Year Est. Return
+177.72%
5 Year Est. Return
+262.7%
10 Year Est. Return
+1,121.27%
AUM
$20.6B
AUM Growth
+$1.31B
(+6.8%)
Cap. Flow
-$24.4M
Cap. Flow
% of AUM
-0.12%
Top 10 Holdings %
Top 10 Hldgs %
23.17%
Holding
1,324
New
114
Increased
401
Reduced
595
Closed
142
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
US Bancorp
USB
|
+$107M |
| 2 |
PayPal
PYPL
|
+$95.5M |
| 3 |
PepsiCo
PEP
|
+$94.2M |
| 4 |
Bank of America
BAC
|
+$88.1M |
| 5 |
UnitedHealth
UNH
|
+$87.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLA
KLAC
|
+$138M |
| 2 |
Microsoft
MSFT
|
+$92.2M |
| 3 |
Public Storage
PSA
|
+$88.3M |
| 4 |
Qualcomm
QCOM
|
+$85.2M |
| 5 |
Robert Half
RHI
|
+$76.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.95% |
| 2 | Healthcare | 15.44% |
| 3 | Financials | 14.85% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Consumer Staples | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Entegris
ENTG
$25B
| $583K | ﹤0.01% |
8,883
-239,082
| -96% | -$17.6M |
|
|
TVRD
852
Tvardi Therapeutics
TVRD
$22.1M
| $582K | ﹤0.01% |
1,505
-1,146
| -43% | -$435K |
|
853
Lindblad Expeditions
LIND
$2.26B
| $582K | ﹤0.01% |
+75,553
| New | +$638K |
|
854
Denali Therapeutics
DNLI
$3.97B
| $581K | ﹤0.01% |
20,902
-21,839
| -51% | -$650K |
|
855
Brady Corp
BRC
$4.43B
| $581K | ﹤0.01% |
12,341
-1,334
| -10% | -$61.1K |
|
856
HEICO Corp Class A
HEI.A
$38.1B
| $578K | ﹤0.01% |
4,820
-76
| -2% | -$9.28K |
|
857
Oil States International
OIS
$526M
| $577K | ﹤0.01% |
77,290
| – | – |
|
858
Universal Logistics Holdings
ULH
$518M
| $570K | ﹤0.01% |
17,060
| – | – |
|
859
Vitamin Cottage Natural Grocers
NGVC
$646M
| $566K | ﹤0.01% |
61,951
+440
| +0.7% | +$4.63K |
|
|
BRKL
860
DELISTED
Brookline Bancorp
BRKL
| $562K | ﹤0.01% |
39,695
-1,900
| -5% | -$25.4K |
|
861
Bloomin' Brands
BLMN
$924M
| $559K | ﹤0.01% |
27,801
-2,650
| -9% | -$57.4K |
|
862
Sana Biotechnology
SANA
$1.1B
| $558K | ﹤0.01% |
141,319
| – | – |
|
863
Arthur J. Gallagher & Co
AJG
$65B
| $558K | ﹤0.01% |
2,958
-48
| -2% | -$8.98K |
|
|
WW
864
DELISTED
WW International
WW
| $557K | ﹤0.01% |
144,275
-2,700
| -2% | -$10.8K |
|
865
Utah Medical Products
UTMD
$230M
| $557K | ﹤0.01% |
5,537
| – | – |
|
|
RUTH
866
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $554K | ﹤0.01% |
35,791
-60,825
| -63% | -$1.07M |
|
867
CBIZ
CBZ
$2.96B
| $552K | ﹤0.01% |
11,791
-384
| -3% | -$18.3K |
|
|
PWSC
868
DELISTED
PowerSchool Holdings, Inc.
PWSC
| $549K | ﹤0.01% |
23,774
-2,444
| -9% | -$47.8K |
|
|
PCSB
869
DELISTED
PCSB Financial Corporation
PCSB
| $548K | ﹤0.01% |
28,783
| – | – |
|
870
Clearfield
CLFD
$390M
| $547K | ﹤0.01% |
5,813
-4,808
| -45% | -$507K |
|
|
KNBE
871
DELISTED
KnowBe4, Inc. Class A Common Stock
KNBE
| $547K | ﹤0.01% |
22,061
-40,787
| -65% | -$993K |
|
872
Vishay Intertechnology
VSH
$5.11B
| $545K | ﹤0.01% |
25,255
+600
| +2% | +$12.7K |
|
873
Tredegar Corp
TG
$278M
| $545K | ﹤0.01% |
53,301
-2,510
| -4% | -$26.2K |
|
874
OFG Bancorp
OFG
$2.26B
| $542K | ﹤0.01% |
19,679
-1,184
| -6% | -$32.5K |
|
875
Tenable Holdings
TENB
$4.41B
| $541K | ﹤0.01% |
14,175
+4,981
| +54% | +$183K |
|
Similar funds
FDCDDQ
WP
N
PCH
VAI
Los Angeles Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, Los Angeles Capital Management held 1,324 positions worth $20.6B, up 6.8% from $19.3B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Los Angeles Capital Management's Q4 2022 filing shows 114 new, 401 increased, 595 reduced and 142 closed positions. Its largest new stake was Hologic: 435,924 shares worth $32.6M. The largest sale was KLA, an estimated $138M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 31% a quarter earlier, followed by Healthcare and Financials.
- Los Angeles Capital Management's largest Q4 2022 buy was Hologic: 435,924 shares worth $32.6M.
- Los Angeles Capital Management added most to US Bancorp in Q4 2022, an estimated $107M increase.
- Los Angeles Capital Management's biggest Q4 2022 reduction was KLA, cutting an estimated $138M.
- Los Angeles Capital Management fully exited Knight Transportation in Q4 2022, selling an estimated $31.6M.
- Los Angeles Capital Management's ten largest holdings make up 23% of its $20.6B portfolio in Q4 2022.
- Los Angeles Capital Management opened 114 new positions and closed 142 in Q4 2022.
- Los Angeles Capital Management's portfolio value rose 6.8% quarter-over-quarter to $20.6B.
Based on Los Angeles Capital Management's 13F filing for Q4 2022, filed 6 Feb 2023.